Elbit Medical Technologies Ltd
ELBDF
$0.05
-$0.01-16.67%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -126.38% | -126.38% | 102.56% | 102.56% | 117.23% |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 77.68% | 77.68% | -104.22% | -104.22% | -130.79% |
Change in Net Operating Assets | 114.29% | 114.29% | -25.00% | -25.00% | -180.00% |
Cash from Operations | 11.15% | 11.15% | 13.99% | 13.99% | 2.63% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -81.43% | -81.43% | 9.09% | 9.09% | -92.99% |
Cash from Investing | -81.43% | -81.43% | 9.09% | 9.09% | -92.99% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -- | -- | -- | -- |
Foreign Exchange rate Adjustments | 245.45% | 245.45% | 59.26% | 59.26% | 11.29% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 25.59% | 25.59% | 24.47% | 24.47% | -112.93% |